Boston’s Downtown Is in Trouble and Needs Reinvention

Prasad came to the Food & Drug Administration in May, hoping to set high, evidence-based standards for new medicines. He didn’t even last three months. The industry’s power has never been clearer.

David Hogg has had an interesting summer.

This post was originally published on this site